Below are 10 legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.
1. Former CVS exec can't work at Amazon's pharmacy, judge rules
A federal judge has barred a former CVS Caremark executive from working at PillPack, the online pharmacy acquired by Amazon last year.
2. Chicago biotech sues venture capital firm, Bluebird Bio CEO over attempt to 'kill' rival medical treatment
Errant Gene Therapeutics, a biotech company based in Chicago, is suing a venture capital firm and BlueBird Bio's CEO, claiming the two parties worked to 'kill' a competing medical treatment.
3. Drugmakers sue HHS to halt price disclosures in TV ads
Three major U.S. drugmakers have sued HHS in an attempt to block a rule that would require them to disclose the list price of prescription drugs in their television advertisements.
4. CVS must face class-action suit, appeals court rules
A federal appeals court revived a class-action lawsuit alleging CVS Health overcharged millions of customers for generic drugs.
5. Amazon's PillPack pharmacy accused of violating customer privacy
PillPack, the online pharmacy acquired by Amazon last year, has been accused of violating customer privacy in separate lawsuits within the last year.
6. Catalyst sues FDA over approval of rival drug
Catalyst Pharmaceuticals has sued the FDA, accusing the agency of violating provisions of the law and its rights to exclusivity for its rare disease drug Firdapse when it approved a lower-cost rival drug.
7. Ohio pharmacy accused of wrongly firing whistle-blower
The U.S. Department of Labor is accusing an Ohio pharmacy of improperly firing one of its techs after concerns were raised about safety lapses.
8. CVS Caremark to pay $15M to settle overtime pay case
CVS Caremark will pay $15.3 million to settle a lawsuit accusing the pharmacy benefit manager of denying overtime pay to employees in its call centers nationwide.
9. Insys to pay $225M to resolve opioid charges
Insys Therapeutics has agreed to pay $225 million to settle allegations of illegally marketing an addictive fentanyl painkiller to physicians, the U.S. Justice Department announced June 5.
10. Mallinckrodt agrees to $15.4M settlement of bribery case
Drugmaker Mallinckrodt has reached a tentative deal with the U.S. Justice Department to resolve a drug bribery case, the manufacturer announced June 5. Mallinckrodt expects to pay out $15.4 million.